The combination medication nirmatrelvir–ritonavir has been shown to reduce progression to severe illness from COVID-19 in unvaccinated high-risk patients, but its effectiveness in patients who have been vaccinated, infected naturally, or both is unclear.

APhA Staff

Hospital-acquired UTIs cost hospitals in the United States more than $3.7 billion annually, yet the strategies guiding prevention have been based almost entirely on one target: the indwelling urinary catheter.

Aiya Almogaber, PharmD

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, remains a common and potentially serious cardiovascular condition that requires prompt anticoagulation to prevent recurrence and death.

Corey Diamond, PharmD

For patients with breast cancer receiving myelosuppressive chemotherapy, pegfilgrastim has become a standard tool for preventing febrile neutropenia, but the bone pain it triggers has remained a stubborn, undertreated problem.

Aiya Almogaber, PharmD

Every 5 years, the offer new and updated recommendations to help clinicians, first responders, and lay rescuers work together to improve survival rates and neurological outcomes for adults, children, and infants experiencing cardiac arrest.

Elizabeth Briand